PMTCT: Addressing low uptake of ARV drugs
14 January 2014
Provision of antiretroviral (ARV) drugs to HIV infected mothers and their newborn babies is a critical component of prevention of mother-to-child transmission (PMTCT) of HIV, and is key to changing the trajectory of the HIV epidemic in sub-Saharan Africa.
But uptake of ARV drugs for PMTCT remains unacceptably low in many countries across sub-Saharan Africa.
This new brief has analysed the evidence available to assess what the barriers are, and makes recommendations of how to address them.Download Addressing low uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa